YolTech Therapeutics Announces Successful Completion of Dose Escalation Phase in Phase I Trial of YOLT-201 for ATTR ...Middle East

SHANGHAI, Dec. 21, 2024 /PRNewswire/ -- YolTech Therapeutics today announced updated data from its ongoing Phase I/IIa clinical trial of YOLT-201, a first-in-class CRISPR/Cas9-based in vivo gene-editing therapy for ATTR amyloidosis. The trial has completed dosing in eight participants,...

Hence then, the article about yoltech therapeutics announces successful completion of dose escalation phase in phase i trial of yolt 201 for attr was published today ( Saturday 21/12/2024 - 11:33 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( YolTech Therapeutics Announces Successful Completion of Dose Escalation Phase in Phase I Trial of YOLT-201 for ATTR )

Also on site :

• Travis County deputy arrested on official oppression charge
• 10 Shows Like 'Your Friends and Neighbors' You Should Watch Next
• Republicans Flirt With Kicking Americans Off Health Care to Fund Iran War